Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study von Lee, Sung-Eun, Choi, Soo Young, Song, Hye-Young, Kim, Soo-Hyun, Choi, Mi-Yeon, Park, Joon Seong, Kim, Hyeoung-Joon, Kim, Sung-Hyun, Zang, Dae Young, Oh, Sukjoong, Kim, Hawk, Do, Young Rok, Kwak, Jae-Yong, Kim, Jeong-A, Kim, Dae-Young, Mun, Yeung-Chul, Lee, Won Sik, Chang, Myung Hee, Park, Jinny, Kwon, Ji Hyun, Kim, Dong-Wook

Volltext

Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry von Yoo, Kwai Han, Kim, Hyeoung-Joon, Min, Yoo Hong, Hong, Dae-Sik, Lee, Won Sik, Kim, Hee-Je, Shin, Ho-Jin, Park, Yong, Lee, Je-Hwan, Kim, Hawk

Volltext

Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE) von Do, Young Rok, Kwak, Jae‐Yong, Kim, Jeong A., Kim, Hyeoung Joon, Chung, Joo Seop, Shin, Ho‐Jin, Kim, Sung‐Hyun, Bunworasate, Udomsak, Choi, Chul Won, Zang, Dae Young, Oh, Suk Joong, Jootar, Saengsuree, Reksodiputro, Ary Harryanto, Lee, Won Sik, Mun, Yeung‐Chul, Kong, Jee Hyun, Caguioa, Priscilla B., Kim, Hawk, Park, Jinny, Kim, Dong‐Wook

Volltext

Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults von Yoo, Kwai Han, Cho, Jinhyun, Han, Boram, Kim, Se Hyung, Shin, Dong-Yeop, Hong, Junshik, Kim, Hawk, Kim, Hyo Jung, Zang, Dae young, Yoon, Sung-Soo, Jin, Jong-Youl, Lee, Jae Hoon, Hong, Dae-Sik, Park, Seong Kyu

Volltext

Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death von Heo, Sook-Kyoung, Noh, Eui-Kyu, Kim, Jeong Yi, Jeong, Yoo Kyung, Jo, Jae-Cheol, Choi, Yunsuk, Koh, SuJin, Baek, Jin Ho, Min, Young Joo, Kim, Hawk

Volltext

Lenalidomide as a second‐line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome von Kim, Hawk, Lee, Je‐Hwan, Lee, Won‐Sik, Kim, Inho, Moon, Joon Ho, Choi, Chul Won, Lee, Ho Sup, Park, Jinny, Choi, Yunsuk, Shin, Ho‐Jin, Cho, Su‐Hee, Kim, Kyoung Ha, Kim, Sung‐Yong, Kim, Yoo‐Jin

Volltext

Dasatinib accelerates valproic acid-induced acute myeloid leukemia cell death by regulation of differentiation capacity von Heo, Sook-Kyoung, Noh, Eui-Kyu, Yoon, Dong-Joon, Jo, Jae-Cheol, Park, Jae-Hoo, Kim, Hawk

Volltext

Diagnosis and treatment of transfusion-related iron overload von Kim, Hawk

Volltext

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study von Kim, Seok Jin, Lee, Jong Wook, Jung, Chul Won, Min, Chang Ki, Cho, Bin, Shin, Ho Jin, Chung, Joo Seop, Kim, Hawk, Lee, Won Sik, Joo, Young Don, Yang, Deok-Hwan, Kook, Hoon, Kang, Hyoung Jin, Ahn, Hyo Seop, Yoon, Sung-Soo, Sohn, Sang Kyun, Min, Yoo Hong, Min, Woo-Sung, Park, Hee-Sook, Won, Jong Ho

Volltext

Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study von Lee, Je-Hwan, Kim, Yoo-Jin, Sohn, Sang Kyun, Yoon, Sung-Soo, Kim, Hawk, Cheong, June-Won, Lee, Won-Sik, Lee, Gyeong-Won, Lim, Sung-Nam, Kim, Min Kyoung, Lee, Ho Sup, Kim, Hyeoung-Joon

Volltext

Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey von Uhm, Jieun, Kim, Kyoung Ha, Lee, Hyewon, Kim, Hawk, Cassandra, Slader, Joo, Inkyung, Jung, Chul Won

Volltext

Genome‐wide genotype‐based risk model for survival in acute myeloid leukaemia patients with normal karyotype von Choi, Hangseok, Jung, Chulwon, Sohn, Sang Kyun, Kim, Seonwoo, Kim, Hyeoung‐Joon, Kim, Yeo‐Kyeoung, Kim, TaeHyung, Zhang, Zhaolei, Shin, Eun‐Soon, Lee, Jong‐Eun, Moon, Joon Ho, Kim, Sung Hyun, Kim, Kyoung Ha, Mun, Yeung‐Chul, Kim, Hawk, Park, Jinny, Kim, Jhingook, Kim, Dennis (D. H.)

Volltext

Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity von Hong, Junshik, Lee, Yoo Jin, Bae, Sung Hwa, Yi, Jun Ho, Park, Sungwoo, Chang, Myung Hee, Park, Young Hoon, Hyun, Shin Young, Chung, Joo-Seop, Jang, Ji Eun, Jung, Joo Young, Jeon, So-Yeon, Song, Seo-Young, Kim, Hawk, Kim, Dae Sik, Kim, Sung-Hyun, Kim, Min Kyoung, Han, Sang Hoon, Park, Seonyang, Kim, Yoo-Jin, Lee, Je-Hwan

Volltext

No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome von Sohn, Sang Kyun, Moon, Joon Ho, Lee, In Hee, Ahn, Jae Sook, Kim, Hyeoung Joon, Chung, Joo Seop, Shin, Ho Jin, Park, Sung Woo, Lee, Won Sik, Lee, Sang Min, Kim, Hawk, Lee, Ho Sup, Kim, Yang Soo, Cho, Yoon Young, Bae, Sung Hwa, Lee, Ji Hyun, Kim, Sung Hyun, Song, Ik Chan, Kwon, Ji Hyun, Lee, Yoo Jin

Volltext

Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL) von Park, Silvia, Lee, Su Jin, Kim, Kihyun, Jang, Jun Ho, Kim, Dong Hwan, Lee, Kyu Hyung, Lee, Je Hwan, Lee, Jung Hee, Kim, Dae Young, Jang, Dae-Young, Kim, Hawk, Park, Jae Hoo, Ryoo, Hun Mo, Bae, Sung Hwa, Kim, Min Kyung, Hyun, Myung Soo, Joo, Young Don, Lee, Won Sik, Lee, Sang Min, Jung, Chul Won

Volltext

Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Mul... von Park, Sang Hyuk, Lee, Hyun Ji, Kim, In-Suk, Kang, Jeong-Eun, Lee, Eun Yup, Kim, Hyeoung-Joon, Kim, Yeo-Kyeoung, Won, Jong-Ho, Bang, Soo Mee, Kim, Hawk, Song, Moo-Kon, Chung, Joo Seop, Shin, Ho-Jin

Volltext

Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type von Jo, Jae-Cheol, Kim, Misung, Choi, Yunsuk, Kim, Hyun-Jung, Kim, Ji Eun, Chae, Seoung Wan, Kim, Hawk, Cha, Hee Jeong

Volltext

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia von Lee, Je-Hwan, Joo, Young-Don, Kim, Hawk, Bae, Sung Hwa, Kim, Min Kyoung, Zang, Dae Young, Lee, Jung-Lim, Lee, Gyeong Won, Lee, Jung-Hee, Park, Jae-Hoo, Kim, Dae-Young, Lee, Won-Sik, Ryoo, Hun Mo, Hyun, Myung Soo, Kim, Hyo Jung, Min, Young Joo, Jang, Yae-Eun, Lee, Kyoo-Hyung

Volltext

Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia von Lee, Je-Hwan, Kim, Hawk, Joo, Young-Don, Lee, Won-Sik, Bae, Sung Hwa, Zang, Dae Young, Kwon, Jihyun, Kim, Min Kyoung, Lee, Junglim, Lee, Gyeong Won, Lee, Jung-Hee, Choi, Yunsuk, Kim, Dae-Young, Hur, Eun-Hye, Lim, Sung-Nam, Lee, Sang-Min, Ryoo, Hun Mo, Kim, Hyo Jung, Hyun, Myung Soo, Lee, Kyoo-Hyung

Volltext

Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials von Shin, Dong-Yeop, Park, Sahee, Jang, Eunjung, Kong, Jee Hyun, Won, Young-Woong, Oh, Sukjoong, Choi, Yunsuk, Kim, Jeong-A, Lee, Se Won, Mun, Yeung-Chul, Kim, Hawk, Kim, Sung-Hyun, Rok Do, Young, Kwak, Jae-Yong, Kim, Hyeoung-Joon, Zang, Dae Young, Lim, Sung-Nam, Lee, Won Sik, Kim, Dong-Wook

Volltext